|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ESPERION THERAPEUTICS INC/MI, 10-Q, 2000-11-14 |
Next: WORLD DIAGNOSTICS INC, 10QSB, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 759,638
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 76,404
<PP&E> 3,210
<DEPRECIATION> (988)
<TOTAL-ASSETS> 82,872
<CURRENT-LIABILITIES> (7,537)
<BONDS> 0
0
0
<COMMON> (26)
<OTHER-SE> (72,826)
<TOTAL-LIABILITY-AND-EQUITY> (82,872)
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 23,267
<OTHER-EXPENSES> (1,256)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (22,011)
<INCOME-TAX> 0
<INCOME-CONTINUING> (22,011)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> (22,870)
<NET-INCOME> (44,881)
<EPS-BASIC> (7.14)
<EPS-DILUTED> (7.14)
</TABLE>
|
|